All products / DC7820
ARQ 621
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $800 USDRequest a quote / confirm availability → |
| 250 mg | $1,450 USDRequest a quote / confirm availability → |
| 1 g | $2,900 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
ARQ 621 demonstrates anti-tumor activity against a wide range of human cancer cell lines in vitro, including colon, lung, endometrial, bladder, and hematologic cancer cell lines, with significantly less cytotoxicity against hematopoietic cells. ARQ 621, as a novel clinical stage drug candidate, inhibits a number of xenografts grown in athymic mice, such as pancreatic, breast, prostate, and ovarian carcinomas with no hematological changes. Furthermore, for ARQ 621, there is no envidence of bone marrow toxicity in pre-clinical mouse efficacy models or safety studies in rats and dogs. For the detailed information of ARQ 621, the solubility of ARQ 621 in water, the solubility of ARQ 621 in DMSO, the solubility of ARQ 621 in PBS buffer, the animal experiment (test) of ARQ 621, the cell expriment (test) of ARQ 621, the in vivo, in vitro and clinical trial test of ARQ 621, the EC50, IC50,and affinity,of ARQ 621, Please contact DC Chemicals.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC7820 |
|---|---|
| Product name | ARQ 621 |
| CAS | 1095253-39-6 |
| Molecular formula | C28H24Cl2FN5O2 |
| Molecular weight | 552.43 |
| Purity | >98% |
| SMILES | C#CC[C@H](c1nc2cc(Cl)ccc2c(=O)n1Nc1ccccc1)N(CCCN)C(=O)c1cccc(Cl)c1F |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — ARQ 621 (DC7820)